Though official enrollment for the PANDORA Clinical Trial began in August 2020, it has not escaped the team that both the United States and the world have been undergoing and working through the effects of the COVID-19 virus. However, the PANDORA team has been working closely with fellow healthcare providers and departments to ensure the priority of safety to patients who may part take in our clinical study.

By collaborating with safety and regulatory authorities in our centers, we are working to not only make our responses the most effective and appropriate to this situation but also hoping to support our patients during this time in order to better protect their health. In taking these adaptive steps and precautions, our team has found a more comfortable and assuring approach in continuing enrollment and progress of the PANDORA Clinical Trial. We thank all those involved and those who have supported our research during this critical time in the healthcare and research community, as we strive to provide the best care for our patients.

-The PANDORA Study Team